Evidence map›Paper›PMID 29579041›Full record

ArticlePLoS genetics2018

The CSR-1 endogenous RNAi pathway ensures accurate transcriptional reprogramming during the oocyte-to-embryo transition in Caenorhabditis elegans.

Christina Fassnacht, Cristina Tocchini, Pooja Kumari, Dimos Gaidatzis, Michael B Stadler, Rafal Ciosk

Abstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Multigenerational Regulation of theAnnual review of genetics · 2019
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christina FassnachtFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.ORCID 0000-0001-5379-2687
Cristina TocchiniFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Pooja KumariFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Dimos GaidatzisFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Michael B StadlerFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.ORCID 0000-0002-2269-4934
Rafal CioskFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.ORCID 0000-0003-2234-6216

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endogenous RNAi (endoRNAi) is a conserved mechanism for fine-tuning gene expression. In the nematode Caenorhabditis elegans, several endoRNAi pathways are required for the successful development of reproductive cells. The CSR-1 endoRNAi pathway promotes germ cell development, primarily by facilitating the expression of germline genes. In this study, we report a novel function for the CSR-1 pathway in preventing premature activation of embryonic transcription in the developing oocytes, which is accompanied by a general Pol II activation. This CSR-1 function requires its RNase activity, suggesting that, by controlling the levels of maternal mRNAs, CSR-1-dependent endoRNAi contributes to an orderly reprogramming of transcription during the oocyte-to-embryo transition.

Indexed as

RNA InterferenceAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansCaenorhabditis elegans ProteinsEmbryo, NonmammalianFemaleGene Expression Regulation, DevelopmentalMutationOocytesRNA Polymerase IITranscription FactorsCaenorhabditis elegans ProteinsCSR-1 protein, C elegansGLD-1 protein, C elegansLIN-41 protein, C elegansRNA Polymerase IITranscription Factors

Identifiers

PMID29579041
PMCPMC5886687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.